Innoviva
INVA
#5092
Rank
โ‚ฌ1.34 B
Marketcap
18,03ย โ‚ฌ
Share price
1.25%
Change (1 day)
-0.61%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2025 (TTM): โ‚ฌ0.13 Billion

According to Innoviva's latest financial reports the company's current earnings are โ‚ฌ0.38 Billion. In 2024 the company made an earning of โ‚ฌ32.1 Million a decrease over its 2023 earnings that were of โ‚ฌ0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.13 B314.27%
2024 โ‚ฌ32.1 M-80.74%
2023 โ‚ฌ0.16 B-32.36%
2022 โ‚ฌ0.24 B-35.56%
2021 โ‚ฌ0.38 B25.7%
2020 โ‚ฌ0.30 B52.11%
2019 โ‚ฌ0.19 B10.77%
2018 โ‚ฌ0.18 B56.59%
2017 โ‚ฌ0.11 B125.53%
2016 โ‚ฌ51.12 M-417.36%
2015 -โ‚ฌ16.11 Million-74.49%
2014 -โ‚ฌ63.15 Million-25.19%
2013 -โ‚ฌ84.4 Million430.06%
2012 -โ‚ฌ15.93 Million-83.92%
2011 -โ‚ฌ99.05 Million39.82%
2010 -โ‚ฌ70.85 Million2.84%
2009 -โ‚ฌ68.89 Million-8.62%
2008 -โ‚ฌ75.39 Million-47.92%
2007 -โ‚ฌ0.15 Billion-5.92%
2006 -โ‚ฌ0.16 Billion19.8%
2005 -โ‚ฌ0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-โ‚ฌ15.6 Million-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-โ‚ฌ0.14 Billion-201.89%๐Ÿ‡บ๐Ÿ‡ธ USA